23andMe is reportedly considering the sale of Lemonaid Health, its telehealth operation. The consumer genetic testing kit company acquired Lemonaid in 2021 for $400 million...
Hims & Hers Health has had its biggest one-day loss in over two months, following its rival 23andMe’s agreement to buy web-based healthcare platform Lemonaid...